Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on February 7, 2005

Hypertension. 2005
Published online before print February 7, 2005, doi: 10.1161/01.HYP.0000155212.33212.99
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/4/804    most recent
01.HYP.0000155212.33212.99v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, C.
Right arrow Articles by Jose, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, C.
Right arrow Articles by Jose, P. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Other hypertension

Submitted on October 10, 2004
Revised on November 1, 2004

Interaction of Angiotensin II Type 1 and D5 Dopamine Receptors in Renal Proximal Tubule Cells

Chunyu Zeng*; Zhiwei Yang; Zheng Wang; John Jones; Xiaoyan Wang; Joanna Altea; Amy J. Mangrum; Ulrich Hopfer; David R. Sibley; Gilbert M. Eisner; Robin A. Felder; and Pedro A. Jose

From the Department of Cardiology (C.Z.), Daping Hospital, Third Military Medical University, Chongqing, P.R. China; Departments of Pediatrics (Z.Y., Z.W., J.J., X.W., J.A., P.A.J.), Physiology and Biophysics (Z.Y., P.A.J.), and Medicine (G.M.E.), Georgetown University Medical Center, Washington, DC; Departments of Medicine (A.J.M.) and Pathology (R.A.F.), University of Virginia Health Sciences Center, Charlottesville; Department of Physiology and Biophysics (U.H.), Case Western Reserve School of Medicine, Cleveland, Ohio; and Molecular Neuropharmacology Section (D.R.S.), National Institute of Neurological Disorders and Stroke/NIH, Bethesda, Md.

* To whom correspondence should be addressed. E-mail: cyzeng1{at}hotmail.com.

Abstract--Angiotensin II type 1 (AT1) receptor and D1 and D3 dopamine receptors directly interact in renal proximal tubule (RPT) cells from normotensive Wistar-Kyoto rats (WKY). There is indirect evidence for a D5 and AT1 receptor interaction in WKY and spontaneously hypertensive rats (SHR). Therefore, we sought direct evidence of an interaction between AT1 and D5 receptors in RPT cells. D5 and AT1 receptors colocalized in WKY cells. Angiotensin II decreased D5 receptors in WKY cells in a time- and concentration-dependent manner (EC50=2.7x10-9 M; t1/2=4.9 hours), effects that were blocked by an AT1 receptor antagonist (losartan). In SHR, angiotensin II (10-8 M/24 hours) also decreased D5 receptors (0.96±0.08 versus 0.72±0.08; n=12) and to the same degree as in WKY cells (1.44±0.07 versus 0.92±0.08). However, basal D5 receptors were decreased in SHR RPT cells (SHR 0.96±0.08; WKY 1.44±0.07; n=12 per strain; P<0.05) and renal brush border membranes of SHR compared with WKY (SHR 0.54±0.16 versus WKY 1.46±0.10; n=5 per strain; P<0.05). Angiotensin II decreased AT1 receptor expression in WKY (1.00±0.04 versus 0.72±0.08; n=8; P<0.05) but increased it in SHR (0.96±0.04 versus 1.32±0.08; n=8; P<0.05). AT1 and D5 receptors also interacted in vivo; renal D5 receptor protein was higher in mice lacking the AT1A receptor (AT1A-/-; 1.61±0.31; n=6) than in wild-type littermates used as controls (AT1A+/+; 0.81±0.08; n=6; P<0.05), and renal cortical AT1 receptor protein was higher in D5 receptor null mice than in wild-type littermates (1.18±0.08 versus 0.84±0.07; n=4; P<0.05). We conclude that D5 and AT1 receptors interact with each other. Altered interactions between AT1 and dopamine receptors may play a role in the pathogenesis of hypertension.


Key words: receptors, dopamine • receptors, angiotensin II • rats, spontaneously hypertensive • normotension • kidney




This article has been cited by other articles:


Home page
HypertensionHome page
H. Li, W. Han, V. A. M. Villar, L. B. Keever, Q. Lu, U. Hopfer, M. T. Quinn, R. A. Felder, P. A. Jose, and P. Yu
D1-Like Receptors Regulate NADPH Oxidase Activity and Subunit Expression in Lipid Raft Microdomains of Renal Proximal Tubule Cells
Hypertension, June 1, 2009; 53(6): 1054 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H.-H. Hsu, K. Duning, H. H. Meyer, M. Stolting, T. Weide, S. Kreusser, T. van Le, C. Gerard, R. Telgmann, S.-M. Brand-Herrmann, et al.
Hypertension in mice lacking the CXCR3 chemokine receptor
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F780 - F789.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. S. Wilcox and A. Pearlman
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, V. A. M. Villar, G. M. Eisner, S. M. Williams, R. A. Felder, and P. A. Jose
G Protein-Coupled Receptor Kinase 4: Role in Blood Pressure Regulation
Hypertension, June 1, 2008; 51(6): 1449 - 1455.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Gildea, X. Wang, P. A. Jose, and R. A. Felder
Differential D1 and D5 Receptor Regulation and Degradation of the Angiotensin Type 1 Receptor
Hypertension, February 1, 2008; 51(2): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Mogi, M. Iwai, and M. Horiuchi
Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2532 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Wang, I. Armando, L. D. Asico, C. Escano, X. Wang, Q. Lu, R. A. Felder, C. G. Schnackenberg, D. R. Sibley, G. M. Eisner, et al.
The elevated blood pressure of human GRK4{gamma} A142V transgenic mice is not associated with increased ROS production
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2083 - H2092.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, Z. Wang, H. Li, P. Yu, S. Zheng, L. Wu, L. D. Asico, U. Hopfer, G. M. Eisner, R. A. Felder, et al.
D3 Dopamine Receptor Directly Interacts With D1 Dopamine Receptor in Immortalized Renal Proximal Tubule Cells
Hypertension, March 1, 2006; 47(3): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, Z. Wang, U. Hopfer, L. D. Asico, G. M. Eisner, R. A. Felder, and P. A. Jose
Rat Strain Effects of AT1 Receptor Activation on D1 Dopamine Receptors in Immortalized Renal Proximal Tubule Cells
Hypertension, October 1, 2005; 46(4): 799 - 805.
[Abstract] [Full Text] [PDF]